Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of neural transmission

• Publication date

  2014-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00702-013-1130-xPMID 24318540PMCID PMC4048804
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Original Papers

  2015cited by this paper
• Sub-Anesthetic Ketamine Modulates Intrinsic BOLD Connectivity Within the Hippocampal-Prefrontal Circuit in the Rat

  2014cited by this paper
• Clinical predictors of ketamine response in treatment-resistant major depression.

  2014cited by this paper
• Neural correlates of rapid antidepressant response to ketamine in bipolar disorder

  2014cited by this paper
• Do the dissociative side effects of ketamine mediate its antidepressant effects?

  2014cited by this paper
• Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder.

  2013cited by this paper
• Glutamate normalization with ECT treatment response in major depression

  2013cited by this paper
• Synaptic Abnormalities in the Infralimbic Cortex of a Model of Congenital Depression

  2013cited by this paper
• The β-catenin destruction complex.

  2013cited by this paper
• The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors.

  2013cited by this paper
• Human biomarkers of rapid antidepressant effects.

  2013cited by this paper
• A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression

  2013cited by this paper
• Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder.

  2013cited by this paper
• Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

  2013cited by this paper
• Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.

  2013cited by this paper
• Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?

  2013cited by this paper
• Effects of S-Ketamine as an Anesthetic Adjuvant to Propofol on Treatment Response to Electroconvulsive Therapy in Treatment-Resistant Depression: A Randomized Pilot Study

  2013cited by this paper
• A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.

  2013cited by this paper
• Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity.

  2013cited by this paper
• Vitamin B12 Level may be Related to the Efficacy of Single Ketamine Infusion in Bipolar Depression

  2013cited by this paper
• GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine

  2013cited by this paper
• A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression.

  2013cited by this paper
• Selective breeding for helplessness in rats alters the metabolic profile of the hippocampus and frontal cortex: a 1H-MRS study at 9.4 T.

  2013cited by this paper
• Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

  2013cited by this paper
• Ketamine regulates the presynaptic release machinery in the hippocampus.

  2013cited by this paper
• N-acetylcysteine augmentation to tranylcypromine in treatment-resistant major depression.

  2013cited by this paper
• Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

  2013cited by this paper
• Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.

  2013cited by this paper
• Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression.

  2012cited by this paper
• Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.

  2012cited by this paper
• Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine.

  2012cited by this paper
• The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder.

  2012cited by this paper
• Targeting the Glutamatergic System to Treat Major Depressive Disorder

  2012cited by this paper
• Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.

  2012cited by this paper
• An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.

  2012cited by this paper
• Calcium control of neurotransmitter release.

  2012cited by this paper
• Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.

  2012cited by this paper
• Connecting inflammation with glutamate agonism in suicidality

  2012cited by this paper
• The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.

  2012cited by this paper
• Overview of glutamatergic neurotransmission in the nervous system.

  2012cited by this paper
• Signaling pathways underlying the rapid antidepressant actions of ketamine.

  2012cited by this paper
• Dextromethorphan and quinidine combination in emotional lability associated with depression: a case report.

  2012cited by this paper
• Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study

  2012cited by this paper
• Synaptic Dysfunction in Depression: Potential Therapeutic Targets

  2012cited by this paper
• Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.

  2012cited by this paper
• Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial.

  2012cited by this paper
• Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.

  2012cited by this paper
• Circulating Glial-derived neurotrophic factor is reduced in late-life depression.

  2012cited by this paper
• Synaptic mechanisms underlying rapid antidepressant action of ketamine.

  2012cited by this paper
• Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.

  2012cited by this paper
• An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.

  2012cited by this paper
• The membrane fusion enigma: SNAREs, Sec1/Munc18 proteins, and their accomplices--guilty as charged?

  2012cited by this paper
• ¹H-[¹³C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism.

  2012cited by this paper
• A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder

  2012cited by this paper
• On the safety and benefits of repeated intravenous injections of ketamine for depression.

  2012cited by this paper
• Effects of Propofol and Ketamine as Combined Anesthesia for Electroconvulsive Therapy in Patients With Depressive Disorder

  2012cited by this paper
• Memantine for late‐life depression and apathy after a disabling medical event: a 12‐week, double‐blind placebo‐controlled pilot study

  2012cited by this paper
• Mood and Pain Responses to Repeat Dose Intramuscular Ketamine in a Depressed Patient with Advanced Cancer

  2012cited by this paper
• Rapid Antidepressant Effect of Ketamine in the Electroconvulsive Therapy Setting

  2012cited by this paper
• Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

  2012cited by this paper
• Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression.

  2012cited by this paper
• Compounded oral ketamine.

  2012cited by this paper
• Cellular pathology within the anterior cingulate cortex of patients with late-life depression: a morphometric study.

  2011cited by this paper
• A case of sustained remission following an acute course of ketamine in treatment-resistant depression.

  2011cited by this paper
• Concerns about dextromethorphan as a potential rapid-acting antidepressant.

  2011cited by this paper
• Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.

  2011cited by this paper
• A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department.

  2011cited by this paper
• Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

  2011cited by this paper
• Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.

  2011cited by this paper
• Clinical practice. Bipolar disorder--a focus on depression.

  2011cited by this paper
• The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response.

  2011cited by this paper
• Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation.

  2011cited by this paper
• Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.

  2011cited by this paper
• The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

  2011cited by this paper
• Regulation of neural process growth, elaboration and structural plasticity by NF-κB

  2011cited by this paper
• Dextromethorphan as a potential rapid-acting antidepressant.

  2011cited by this paper
• Revisiting AMPA Receptors as an Antiepileptic Drug Target

  2011cited by this paper
• Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.

  2011cited by this paper
• The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

  2011influential reference
• Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder.

  2011cited by this paper
• NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses

  2011cited by this paper
• Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study

  2011cited by this paper
• Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine

  2010cited by this paper
• Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

  2010cited by this paper
• Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.

  2010cited by this paper
• Oral Ketamine for the Rapid Treatment of Depression and Anxiety in Patients Receiving Hospice Care

  2010cited by this paper
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010cited by this paper
• Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder.

  2010cited by this paper
• The use of a series of ketamine infusions in two patients with treatment-resistant depression.

  2010cited by this paper
• Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

  2010cited by this paper
• Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.

  2010cited by this paper
• Altered expression of glutamate signaling, growth factor and glia genes in the locus coeruleus of patients with major depression

  2010cited by this paper
• Regulation of AMPA receptors by transmembrane accessory proteins

  2010cited by this paper
• Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.

  2010cited by this paper
• Rapid Antidepressant Effect of Ketamine Anesthesia During Electroconvulsive Therapy of Treatment-Resistant Depression: Comparing Ketamine and Propofol Anesthesia

  2010cited by this paper
• Psychiatric Stress Testing: Novel Strategy for Translational Psychopharmacology

  2010cited by this paper
• Ketamine Inhibits Transcription Factors Activator Protein 1 and Nuclear Factor-&kgr;B, Interleukin-8 Production, as well as CD11b and CD16 Expression: Studies in Human Leukocytes and Leukocytic Cell Lines

  2010cited by this paper
• NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test

  2010cited by this paper
• What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.

  2009cited by this paper
• The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study.

  2009cited by this paper

• Treatment with perampanel alleviates depression-like behavior in mice via modulating GluN2B expression to improve excitatory synaptic transmission

  2026cites this paper
• Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor

  2025cites this paper
• Nitrous oxide for the treatment of depression: a systematic review and meta-analysis

  2025cites this paper
• New advances in small molecule drugs targeting NMDA receptors

  2025cites this paper
• Dapagliflozin Reverses LPS‐Induced Depressive–Like Behavior in Mice via Modulation of Glutamate and NF‐κB

  2025cites this paper
• Enhanced mGluR5 availability marks the antidepressant efficacy in major depressive disorder: an [18F]FPEB PET study

  2025cites this paper
• A Comprehensive Review on Major Depressive Disorder: Exploring Etiology, Pathogenesis and Clinical Approaches

  2025cites this paper
• Significance of NMDA receptor-targeting compounds in neuropsychological disorders: An In-depth Review.

  2025cites this paper
• A Physiological Perspective on Glutamate and its Receptors

  2025influential citation
• Predicting responses of neuromodulation and psychotherapies for major depressive disorder: A coordinate-based meta-analysis of functional magnetic resonance imaging studies.

  2025cites this paper
• Safety and Efficacy of the NMDA‐2b‐Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder

  2025cites this paper
• Sildenafil, alone and in combination with imipramine or escitalopram, display antidepressant-like effects in an adrenocorticotropic hormone-induced (ACTH) rodent model of treatment-resistant depression.

  2024cites this paper
• Ginsenoside Rg1 exerts antidepressant effect by regulating hepatic kynurenine metabolism through promoting the interaction between HNF4α and PGC1α

  2024cites this paper
• Effect of continuous esketamine infusion on brain white matter microstructure in patients with major depression: A diffusion tensor imaging study.

  2024cites this paper
• The Antidepressant- and Anxiolytic-Like Effects of the Phosphodiesterase Type-5 Inhibitor Tadalafil are Associated with the Modulation of the Gut-Brain Axis During CNS Autoimmunity

  2024cites this paper
• Therapeutic Approaches for Treatment and Management of Depressive Disorder: A Comprehensive Review

  2024cites this paper
• The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders

  2024cites this paper
• NMDAR (2C) deletion in astrocytes relieved LPS-induced neuroinflammation and depression.

  2024cites this paper
• SiNiSan exerts antidepressant effects by modulating serotonergic/GABAergic neuron activity in the dorsal raphe nucleus region through NMDA receptor in the adolescent depression mouse model.

  2024cites this paper
• Targeting metaplasticity mechanisms to promote sustained antidepressant actions

  2024cites this paper
• Glutamate’s Effects on the N-Methyl-D-Aspartate (NMDA) Receptor Ion Channel in Alzheimer’s Disease Brain: Challenges for PET Radiotracer Development for Imaging the NMDA Ion Channel

  2023cites this paper
• Sex differences in serum trace elements and minerals levels in unmedicated patients with major depressive episode: The role of suicidal ideation.

  2023cites this paper
• The efficacy and tolerability of inhaled nitrous oxide in major depressive disorder: a systematic review and meta-analysis

  2023cites this paper
• Transcriptomic and behavioral studies reveal that glutamate receptors are involved in depressive-like behavior in adult olive flounder Paralichthys olivaceus

  2023cites this paper
• Simulation of nanocarrier-based targeted delivery of an antidepressant for major depressive disorder

  2023cites this paper
• Association between serum copper, zinc, and selenium concentrations and depressive symptoms in the US adult population, NHANES (2011–2016)

  2023cites this paper
• Neurotransmitter Systems in the Etiology of Major Neurological Disorders: Emerging Insights and Therapeutic Implications.

  2023cites this paper
• Social defeat stress induces genome-wide 5mC and 5hmC alterations in the mouse brain

  2023cites this paper
• Pharmacological evidence for glutamatergic pathway involvement in the antidepressant-like effects of 2-phenyl-3-(phenylselanyl)benzofuran in male Swiss mice

  2023cites this paper
• Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actions

  2023cites this paper
• α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect

  2023cites this paper
• Ketogenic Diet and Inflammation: Implications for Mood and Anxiety Disorders.

  2023cites this paper
• GRIN2B gene expression is increased in the anterior cingulate cortex in major depression.

  2023cites this paper
• Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial.

  2022cites this paper
• Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.

  2022cites this paper
• Targeting neuroinflammation by polyphenols: A promising therapeutic approach against inflammation-associated depression.

  2022cites this paper
• Novel Molecular Targets of Antidepressants

  2022cites this paper
• Advances in extraction methods, chemical constituents, pharmacological activities, molecular targets and toxicology of volatile oil from Acorus calamus var. angustatus Besser

  2022cites this paper
• A functional eEF2K-eEF2 pathway in the NAc is critical for the expression of cocaine-induced psychomotor sensitisation and conditioned place preference

  2022cites this paper
• Putative Mechanisms Underlying the Antidepressant Actions of Ketamine: A Review and Study Proposal

  2022cites this paper
• Exploration for biomarkers of postpartum depression based on metabolomics: A systematic review.

  2022cites this paper
• Depression in Adolescence and Brain-Derived Neurotrophic Factor

  2022cites this paper
• The kynurenine pathway in major depression: What we know and where to next.

  2021cites this paper
• Serotonergic gene-to-gene interaction is associated with mood and GABA concentrations but not with pain-related cerebral processing in fibromyalgia subjects and healthy controls

  2021cites this paper
• Changes in cortical gene expression in major depressive disorders: More evidence implicating inflammatory-related pathways in disease etiology

  2021cites this paper
• Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression

  2021cites this paper
• Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.

  2021cites this paper
• Perturbations in Amino Acid Metabolism in Reserpine-Treated Zebrafish Brain Detected by 1H Nuclear Magnetic Resonance-Based Metabolomics

  2021cites this paper
• Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial

  2021cites this paper
• Low-dose S-ketamine exerts antidepressant-like effects via enhanced hippocampal synaptic plasticity in postpartum depression rats

  2021cites this paper
• Phencynonate hydrochloride exerts antidepressant effects by regulating the dendritic spine density and altering glutamate receptor expression

  2021cites this paper
• Treatment resistant depression

  2021cites this paper
• Machine learning model for predicting Major Depressive Disorder using RNA-Seq data: optimization of classification approach

  2021cites this paper
• GluN2A-ERK-mTOR pathway confers a vulnerability to LPS-induced depressive-like behaviour.

  2021cites this paper
• Efficacy and safety evaluation of safinamide as an add-on treatment to levodopa for parkinson’s disease

  2021cites this paper
• Complete evaluation of retinal function in Major Depressive Disorder: From central slowdown to hyperactive periphery.

  2021cites this paper
• Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression.

  2021cites this paper
• Improved irritability, mood, and quality of life following introduction of perampanel as late adjunctive treatment for epilepsy.

  2020cites this paper
• Conformational flexibility within the small domain of human serine racemase.

  2020cites this paper
• Cinnamomum tamala as an adjuvant therapy in the treatment of major depressive disorder: A double-blind, randomized, placebo-controlled clinical trial with placebo control

  2020cites this paper
• Toward a New Model of Understanding, Preventing, and Treating Adolescent Depression Focusing on Exhaustion and Stress

  2020cites this paper
• Effects and Mechanisms of Electroacupuncture on Chronic Inflammatory Pain and Depression Comorbidity in Mice

  2020cites this paper
• Brain NMDA Receptors in Schizophrenia and Depression

  2020cites this paper
• RAGE signaling pathway in Hippocampus Dentate Gyrus Involved in GLT-1 decrease Induced by Chronic Unpredictable Stress in Rats.

  2020cites this paper
• Fetal growth restriction mice are more likely to exhibit depression‐like behaviors due to stress‐induced loss of dopaminergic neurons in the VTA

  2020cites this paper
• Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety

  2020cites this paper
• Depression following traumatic brain injury: a comprehensive overview

  2020cites this paper
• N-methyl-D-aspartate receptor antagonists decrease interferon-alpha induced depressive behavior in mice model of despair

  2019cites this paper
• mGluR5 and Stress Disorders: Knowledge Gained from Receptor Imaging Studies

  2019cites this paper
• Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity

  2019cites this paper
• The Role of N-methyl-D-aspartate Receptor on Late-Life Depression

  2019cites this paper
• Changed cortical risk gene expression in major depression and shared changes in cortical gene expression between major depression and bipolar disorders

  2019cites this paper
• Neurointegrity and europhysiology: astrocyte, glutamate, and carbon monoxide interactions

  2019cites this paper
• Ketamine exerts a protective role in a cell-based model of major depressive disorder via the inhibition of apoptosis and inflammation and activation of the Krebs cycle

  2019cites this paper
• Targeting Gap Junctions: New Insights in the Treatment of Major Depressive Disorder.

  2019cites this paper
• Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants

  2019cites this paper
• The emergence of depression in teenagers and the role of health professionals

  2019cites this paper
• Investigation of the Mechanisms of Action of Ketamine on the Monoamine Systems: Electrophysiological Studies on the Rat Brain

  2019cites this paper
• Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk

  2019cites this paper
• Blood-Serum Glutamate in Patients with Depressive Disorders as a Potential Peripheral Marker of the Prognosis of the Effectiveness of Therapy

  2018cites this paper
• Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression

  2018cites this paper
• Acupuncture modulates stress response by the mTOR signaling pathway in a rat post-traumatic stress disorder model

  2018cites this paper
• Rapid-Acting Antidepressants: Mechanistic Insights and Future Directions

  2018cites this paper
• Ketamine normalizes brain activity during emotionally valenced attentional processing in depression

  2018cites this paper
• The Role of Magnesium in Neurological Disorders

  2018cites this paper
• Studies of the effect of cerebroprotective substances on the course of stress-induced behavioral depression

  2018cites this paper
• Opposing Roles of Estradiol and Testosterone on Stress-Induced Visceral Hypersensitivity in Rats.

  2018cites this paper
• Investigating the metabolic alterations in a depressive‐like rat model of chronic forced swim stress: An in vivo proton magnetic resonance spectroscopy study at 7T

  2018cites this paper
• Engaging homeostatic plasticity to treat depression

  2018cites this paper
• Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review

  2018cites this paper
• New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity

  2017influential citation
• Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.

  2017influential citation
• Anaesthesia for electroconvulsive therapy – new tricks for old drugs: a systematic review

  2017cites this paper
• Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment.

  2017influential citation
• Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.

  2017cites this paper
• Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study.

  2017cites this paper
• Beyond serotonin: newer antidepressants in the future

  2017cites this paper
• Hippocampal Acetylation may Improve Prenatal-Stress-Induced Depression-Like Behavior of Male Offspring Rats Through Regulating AMPARs Expression

  2017cites this paper
• Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.

  2017cites this paper
• Vitamin D and Depression: Cellular and Regulatory Mechanisms

  2017cites this paper